Home » Topics » Regulatory

Regulatory
RSS

Augmentin's new dosing/formulation cleared by FDA

June 14, 1996

Single-dose hepatitis A vaccine available

June 7, 1996

Tranilast: An angiotensin II antagonist

June 7, 1996

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Transdermal buspirone covered under U.S. patent

June 7, 1996

InSite Vision and Ciba Vision marketing agreement for sustained-release eyedrop formulation

June 7, 1996

Development of AccuSite for basal cell carcinoma delayed

June 7, 1996

Controlled-release naproxen sodium now on U.S. shelves

June 7, 1996

Anika Research seeks European marketing approval for Orthovisc

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...